199 related articles for article (PubMed ID: 19379544)
1. New insights into the biology of filarial infections.
Specht S; Wanji S
J Helminthol; 2009 Jun; 83(2):199-202. PubMed ID: 19379544
[TBL] [Abstract][Full Text] [Related]
2. Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis.
Hoerauf A
Curr Opin Infect Dis; 2008 Dec; 21(6):673-81. PubMed ID: 18978537
[TBL] [Abstract][Full Text] [Related]
3. Elimination of lymphatic filariasis: do we have the drugs to complete the job?
Bockarie MJ; Deb RM
Curr Opin Infect Dis; 2010 Dec; 23(6):617-20. PubMed ID: 20847694
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic filariasis and onchocerciasis.
Taylor MJ; Hoerauf A; Bockarie M
Lancet; 2010 Oct; 376(9747):1175-85. PubMed ID: 20739055
[TBL] [Abstract][Full Text] [Related]
5. Filariasis in Africa--treatment challenges and prospects.
Hoerauf A; Pfarr K; Mand S; Debrah AY; Specht S
Clin Microbiol Infect; 2011 Jul; 17(7):977-85. PubMed ID: 21722251
[TBL] [Abstract][Full Text] [Related]
6. Filaria control and elimination: diagnostic, monitoring and surveillance needs.
Molyneux DH
Trans R Soc Trop Med Hyg; 2009 Apr; 103(4):338-41. PubMed ID: 19181357
[TBL] [Abstract][Full Text] [Related]
7. [Onchocerciasis].
Stingl P
MMW Fortschr Med; 2004 Nov; 146(45):44-5. PubMed ID: 15581105
[TBL] [Abstract][Full Text] [Related]
8. Control of onchocerciasis.
Boatin BA; Richards FO
Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the chemotherapy of lymphatic filariasis.
Navaratnam V
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 2():51-4. PubMed ID: 7973948
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous administration of praziquantel, ivermectin and albendazole, in a community in rural northern Ghana endemic for schistosomiasis, onchocerciasis and lymphatic filariasis.
Anto F; Asoala V; Anyorigiya T; Oduro A; Adjuik M; Akweongo P; Aborigo R; Bimi L; Amankwa J; Hodgson A
Trop Med Int Health; 2011 Sep; 16(9):1112-9. PubMed ID: 21689221
[TBL] [Abstract][Full Text] [Related]
11. Determinants of the eradicability of filarial infections: a conceptual approach.
Duerr HP; Dietz K; Eichner M
Trends Parasitol; 2005 Feb; 21(2):88-96. PubMed ID: 15664532
[TBL] [Abstract][Full Text] [Related]
12. New strategies to combat filariasis.
Hoerauf A
Expert Rev Anti Infect Ther; 2006 Apr; 4(2):211-22. PubMed ID: 16597203
[TBL] [Abstract][Full Text] [Related]
13. Antibiotics for the treatment of onchocerciasis and other filarial infections.
Hoerauf A; Adjei O; Büttner DW
Curr Opin Investig Drugs; 2002 Apr; 3(4):533-7. PubMed ID: 12090719
[TBL] [Abstract][Full Text] [Related]
14. Mass drug treatment for lymphatic filariasis and onchocerciasis.
Molyneux DH; Bradley M; Hoerauf A; Kyelem D; Taylor MJ
Trends Parasitol; 2003 Nov; 19(11):516-22. PubMed ID: 14580963
[No Abstract] [Full Text] [Related]
15. Call to consolidate achievements for onchocerciasis and lymphatic filariasis control.
Hoerauf A; Walter RD; Remme H; Lazdins J; Fleischer B
Trends Parasitol; 2001 Dec; 17(12):566-7. PubMed ID: 11756020
[TBL] [Abstract][Full Text] [Related]
16. Anti-
Wan Sulaiman WA; Kamtchum-Tatuene J; Mohamed MH; Ramachandran V; Ching SM; Sazlly Lim SM; Hashim HZ; Inche Mat LN; Hoo FK; Basri H
Indian J Med Res; 2019 Jun; 149(6):706-714. PubMed ID: 31496523
[TBL] [Abstract][Full Text] [Related]
17. Progress and challenges in the discovery of macrofilaricidal drugs.
Geary TG; Mackenzie CD
Expert Rev Anti Infect Ther; 2011 Aug; 9(8):681-95. PubMed ID: 21819332
[TBL] [Abstract][Full Text] [Related]
18. [Medical treatment of lymphatic filariasis].
Hovette P; Laroche R; Verrot D; Molinier S; Touze JE
Med Trop (Mars); 1991; 51(1):87-90. PubMed ID: 2072855
[TBL] [Abstract][Full Text] [Related]
19. Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis.
Taylor MJ; Hoerauf A; Townson S; Slatko BE; Ward SA
Parasitology; 2014 Jan; 141(1):119-27. PubMed ID: 23866958
[TBL] [Abstract][Full Text] [Related]
20. Is anthelmintic resistance a concern for heartworm control? What can we learn from the human filariasis control programs?
Prichard RK
Vet Parasitol; 2005 Oct; 133(2-3):243-53. PubMed ID: 16198824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
